ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 134 filers reported holding ACLARIS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,208 | +133.2% | 4,264 | +253.0% | 0.00% | – |
| Q2 2023 | $12,527 | +73588.2% | 1,208 | -41.9% | 0.00% | -100.0% |
| Q1 2023 | $17 | +70.0% | 2,078 | +224.7% | 0.00% | – |
| Q4 2022 | $10 | -100.0% | 640 | -91.9% | 0.00% | -100.0% |
| Q3 2022 | $125,000 | -32.1% | 7,931 | -39.9% | 0.00% | -50.0% |
| Q2 2022 | $184,000 | +736.4% | 13,200 | +915.4% | 0.00% | – |
| Q1 2022 | $22,000 | 0.0% | 1,300 | -10.4% | 0.00% | – |
| Q4 2021 | $22,000 | -81.7% | 1,451 | -78.2% | 0.00% | -100.0% |
| Q3 2021 | $120,000 | -19.5% | 6,670 | -21.1% | 0.00% | -25.0% |
| Q2 2021 | $149,000 | +776.5% | 8,457 | +1123.9% | 0.00% | – |
| Q1 2021 | $17,000 | +750.0% | 691 | +153.1% | 0.00% | – |
| Q4 2020 | $2,000 | – | 273 | +25.2% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 218 | -96.2% | 0.00% | – |
| Q3 2019 | $7,000 | +16.7% | 5,774 | +510.4% | 0.00% | – |
| Q1 2019 | $6,000 | -14.3% | 946 | +103.9% | 0.00% | -100.0% |
| Q3 2018 | $7,000 | +600.0% | 464 | +887.2% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 47 | +74.1% | 0.00% | – |
| Q3 2017 | $1,000 | -66.7% | 27 | -69.0% | 0.00% | – |
| Q1 2017 | $3,000 | +50.0% | 87 | -13.0% | 0.00% | – |
| Q2 2016 | $2,000 | -50.0% | 100 | -46.2% | 0.00% | -100.0% |
| Q1 2016 | $4,000 | -81.8% | 186 | -77.1% | 0.00% | -75.0% |
| Q4 2015 | $22,000 | – | 812 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |